Showing results (241-250 of 297) with videos related to

Sort By:
Pageof 30
Cell Reports|October 13, 2021
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatomeJ J David Ho, Tyler A Cunningham, Paola Manara, et al.
Cancers|May 13, 2026
Transferrin Receptor Overexpression in Solid Tumors Is Associated with Inflamed Microenvironments and Upregulated Immune Checkpoints, with Implications for Immunotherapy SensitivityAsaad Trabolsi, Marianna Lekakis, Peter M Commisso, et al.
Physical Review Letters|November 5, 2004
Mass measurement on the rp-process waiting point 72KrD Rodríguez, V S Kolhinen, G Audi, et al.
Physical Review Letters|February 28, 2002
Elastic alpha-12C scattering and the 12C(alpha,gamma)16O E2 S factorP Tischhauser, R E Azuma, L Buchmann, et al.
Bioorganic & Medicinal Chemistry Letters|August 1, 2017
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4AJoseph Tillotson, Magdalena Kedzior, Larissa Guimarães, et al.
Physical Review Letters|October 31, 2025
Crust Composition and the Shallow Heat Source in KS 1731-260R Jain, E F Brown, H Schatz, et al.
Cancer Research|May 29, 2015
Evidence Suggesting That Discontinuous Dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ TumorsAmit Dipak Amin, Soumya S Rajan, Winnie S Liang, et al.
Blood Cancer Journal|February 2, 2025
Bruton's tyrosine kinase inhibition re-sensitizes multidrug-resistant DLBCL tumors driven by BCL10 gain-of-function mutants to venetoclaxCaroline A Coughlin, Dhanvantri Chahar, Marianna Lekakis, et al.
Cancer Research|November 12, 2020
Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin ReceptorsArtavazd Arumov, Piumi Y Liyanage, Asaad Trabolsi, et al.
Blood|April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaMichael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
Pageof 30